Thytech is a health technology company that develops sophisticated cell therapies to restore immunological balance.
Thytech has raised $381K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2022.
Thytech's investors include Banco Sabadell, GENESIS Biomed.
Thytech is headquartered in Madrid, Spain.
Thytech is a health technology company that develops sophisticated cell therapies to restore immunological balance.
Thytech is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Thytech — Funding & Investors." VCBacked, April 8, 2022, https://www.vcbacked.co/company/thytech. Accessed August 13, 2026.
VCBacked. (2022). Thytech — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/thytech
{{cite web |title=Thytech — Funding & Investors |url=https://www.vcbacked.co/company/thytech |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated